Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 and Brain Function in Obesity and Healthy Subjects
NCT03414333Completed
- Sponsor
- University of Pisa
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of Glucagon-like peptide 1 in cognitive impairment, sponsored by University of Pisa. Primary endpoint: Sustained Weight Loss at 6 months. Started Jun 2016; status: completed.
02
Drugs
Glucagon-like peptide 1
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT03414333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03414333.